Form N-CSRS - Certified Shareholder Report, Semi-Annual:
SEC Accession No. 0001104659-22-068021
Filing Date
2022-06-03
Accepted
2022-06-03 15:01:43
Documents
14
Period of Report
2022-03-31
Effectiveness Date
2022-06-03

Document Format Files

Seq Description Document Type Size
1 N-CSRS tm228076d1_ncsrs.htm N-CSRS 830473
2 EXHIBIT 99.CERT tm228076d1_ex99cert.htm EX-99.CERT 19586
3 EXHIBIT 19.SECTION19(A) tm228076d1_ex99section19a.htm EX-19.SECTION19(A) 51856
4 EXHIBIT 99.906 CERT tm228076d1_ex99-906cert.htm EX-99.906 CERT 4270
5 GRAPHIC j2280762_aa001.jpg GRAPHIC 10616
6 GRAPHIC j2280762_aa002.jpg GRAPHIC 10881
7 GRAPHIC j2280762_aa003.jpg GRAPHIC 12929
8 GRAPHIC j2280762_ba004.jpg GRAPHIC 28583
9 GRAPHIC j2280762_ba005.jpg GRAPHIC 8151
10 GRAPHIC j2280762_ba006.jpg GRAPHIC 11338
11 GRAPHIC j2280762_ba007.jpg GRAPHIC 19696
12 GRAPHIC j2280762_ba008.jpg GRAPHIC 26217
13 GRAPHIC j2280762_ba009.jpg GRAPHIC 28485
14 GRAPHIC j2280762_ba010.jpg GRAPHIC 27962
  Complete submission text file 0001104659-22-068021.txt   1163322
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CSRS | Act: 40 | File No.: 811-06565 | Film No.: 22994033